BioModels, a Boston-based preclinical Contract Research Organization, has consistently provided our biotech, pharmaceutical, and academic clients with expertly conducted and highly translational rodent models of disease since our inception in 1997. Our scientific expertise spans the fields of immunology/inflammation, with expertise in IBD, as well as cancer supportive care, pulmonary disease, fibrosis, oncology, and many other indications. We’ve conducted studies in collaboration with more than 300 unique companies over the past decade. Many of the world’s most respected biotech and pharmaceutical companies regularly rely on BioModels’ expertise and efficiency to conduct their outsourced preclinical research.
What Makes Us Unique?
Personalized Service: We view our clients as collaborators rather than customers. The result is an active engagement in personal service and scientific discussions to develop and execute your studies. At BioModels, you will work with a PhD level scientist who is an expert in your selected disease indication. Your scientific partner will be your primary resource to assist in study design, monitor quality control, and provide timely updates on study progress, allowing for real time decisions that often result in improved study outcomes.
Innovative Solutions: Customized animal models are often needed to keep pace with the ever-changing landscape of medicine and science. BioModels specializes in the development of custom disease models to accommodate novel therapeutics and disease indications for which the current animal models are insufficient or do not exist. For our clients, this results in successful preliminary testing of compounds in emerging (or understudied) therapeutic areas, mechanism of action studies, and the identification of novel molecular biomarkers of disease.
Translational Disease Models: Core to the BioModels mission is to provide clinically relevant and highly translational models of human diseases. Providing this distinctive service at a consistently high level of quality is made possible by the unique blend of professionals comprising the BioModels team. The combination of skill-sets produce an efficient team with a track record of enabling well over 100 novel therapeutics to move from test tube to patients.
Accredited
BioModels has earned accreditation from the Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC) for upholding the highest standards in animal use and care.
BioModels is compliant with all U.S. Department of Agriculture (USDA) standards.
*BioModels is compliant with all Office of Laboratory Animal Welfare (OLAW) policies and guidelines.
